Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(79 sites)
United States
University of Alabama at Birmingham- Site Number : 8400026, Birmingham, Alabama St. Joseph's Hospital and Medical Center- Site Number : 8400019, Phoenix, Arizona University of California Los Angeles Medical Center- Site Number : 8400020, Los Angeles, California Stanford University Medical Center- Site Number : 8400008, Stanford, California Mayo Clinic in Florida- Site Number : 8400031, Jacksonville, Florida Jackson Memorial Hospital- Site Number : 8400030, Miami, Florida AdventHealth Orlando- Site Number : 8400023, Orlando, Florida Tampa General Hospital - Tampa - General Circle- Site Number : 8400015, Tampa, Florida Emory University Hospital- Site Number : 8400027, Atlanta, Georgia Northwestern University- Site Number : 8400003, Chicago, Illinois Loyola University Medical Center- Site Number : 8400025, Maywood, Illinois University of Iowa- Site Number : 8400032, Iowa City, Iowa University of Maryland School of Medicine - Baltimore- Site Number : 8400009, Baltimore, Maryland Johns Hopkins Hospital- Site Number : 8400034, Baltimore, Maryland University of Michigan Health System - Ann Arbor- Site Number : 8400014, Ann Arbor, Michigan Corewell Health - Grand Rapids - Michigan Street Northeast- Site Number : 8400010, Grand Rapids, Michigan NYU Perlmutter Cancer Center - Energy Building- Site Number : 8400001, New York, New York Icahn School of Medicine at Mount Sinai- Site Number : 8400037, New York, New York Columbia University Irving Medical Center- Site Number : 8400002, New York, New York Montefiore Medical Center - Moses Campus- Site Number : 8400036, The Bronx, New York Duke University Medical Center- Site Number : 8400017, Durham, North Carolina Cleveland Clinic - Cleveland- Site Number : 8400005, Cleveland, Ohio The Ohio State University- Site Number : 8400028, Columbus, Ohio Penn Medicine: University of Pennsylvania Health System- Site Number : 8400006, Philadelphia, Pennsylvania Temple University Hospital- Site Number : 8400007, Philadelphia, Pennsylvania Vanderbilt University Medical Center- Site Number : 8400018, Nashville, Tennessee University of Texas - Southwestern Medical Center- Site Number : 8400013, Dallas, Texas Baylor College of Medicine- Site Number : 8400024, Houston, Texas Houston Methodist Hospital- Site Number : 8400021, Houston, Texas University Health System - San Antonio- Site Number : 8400035, San Antonio, Texas Inova Fairfax Hospital- Site Number : 8400004, Falls Church, Virginia Australia
Investigational Site Number : 0360003, Darlinghurst, New South Wales Investigational Site Number : 0360001, Brisbane, Queensland Investigational Site Number : 0360002, Murdoch, Western Australia Austria
Investigational Site Number : 0400001, Vienna Belgium
Investigational Site Number : 0560001, Leuven Investigational Site Number : 0560002, Yvoir Canada
Investigational Site Number : 1240002, Edmonton, Alberta Investigational Site Number : 1240001, Vancouver, British Columbia Investigational Site Number : 1240004, Toronto, Ontario China
Investigational Site Number : 1560004, Beijing Investigational Site Number : 1560002, Chengdu Investigational Site Number : 1560008, Fuzhou Investigational Site Number : 1560007, Guangzhou Investigational Site Number : 1560001, Hangzhou Investigational Site Number : 1560005, Hefei Investigational Site Number : 1560009, Shanghai Investigational Site Number : 1560003, Wuxi Investigational Site Number : 1560006, Zhengzhou Czechia
Investigational Site Number : 2030002, Olomouc Investigational Site Number : 2030001, Prague Denmark
Investigational Site Number : 2080001, Copenhagen Finland
Investigational Site Number : 2460001, Helsinki France
Investigational Site Number : 2500005, Le Plessis-Robinson Investigational Site Number : 2500006, Marseille Investigational Site Number : 2500002, Pessac Investigational Site Number : 2500003, Saint-Herblain Investigational Site Number : 2500001, Suresnes Germany
Investigational Site Number : 2760003, Munich Hungary
Investigational Site Number : 3480001, Budapest India
Investigational Site Number : 2500004, Mumbai Israel
Investigational Site Number : 3760001, Petah Tikva Italy
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano-Site Number : 3800001, Milan, Milano Investigational Site Number : 3800005, Padua, Padova IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione)-Site Number : 3800004, Palermo Fondazione IRCCS Policlinico San Matteo-Site Number : 3800003, Pavia Azienda Ospedaliera Universitaria Senese UOC Malattie Respiratorie e Trapianto Polmonare-Site Number : 3800002, Siena Japan
Brigham & Women's Hospital- Site Number : 8400016, Joso-Shi, Massachusetts Netherlands
Investigational Site Number : 5280001, Groningen Norway
Investigational Site Number : 5780001, Oslo South Korea
Investigational Site Number : 4100004, Yangsan, Gyeongsangnam-do Investigational Site Number : 4100002, Seoul, Seoul-teukbyeolsi Investigational Site Number : 4100001, Seoul, Seoul-teukbyeolsi Investigational Site Number : 4100003, Seoul, Seoul-teukbyeolsi Spain
Investigational Site Number : 7240002, A Coruña, A Coruña [La Coruña] Investigational Site Number : 7240003, Barcelona, Barcelona [Barcelona] Investigational Site Number : 7240001, Santander, Cantabria Investigational Site Number : 7240004, Valencia Sweden
Investigational Site Number : 7520001, Gothenburg